BADIAGA LIQUID (S#352) DIN 02206927
Health Canada record
| Active ingredient(s) | BADIAGA 2 X |
|---|---|
| Dosage form | Liquid |
| Route | Sublingual |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 01-Jun-1997 |
| Current status date | 05-Aug-2009 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BADIAGA
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02108305 | BADIAGA - (2X-30CH) TAB | HOMEOCAN INC. | Tablet | BADIAGA 2 X | Cancelled Post Market |
| 02076527 | HOMEOPATHIC MEDICINE (S NO. 352) DPS 30C | TOTAL HEALTH CENTRE | Drops | BADIAGA 30 C | Cancelled Post Market |
| 02233372 | THOPT | TERRA BOTANICA PRODUCTS LTD. | Liquid | BADIAGA 12 X; BARIUM CARBONATE 12 X; OYSTER SHELLS 12 X; CHARCOAL ACTIVATED 12 X; CONIUM MACULATUM 12 X; FUCUS VESICULOSUS 3 X; IODINE 12 X; POTASSIUM IODIDE 12 X; LYCOPUS VIRGINICUS 12 X; SODIUM CHLORIDE 12 X; PULSATILLA 12 X; SEPIA OFFICINALIS L 12 X; SPONGIA TOSTA 3 X | Cancelled Post Market |